This second paper in a 3-part series on antiracism in pain research across the translational
spectrum focuses on study design factors. Although objectivity is a cornerstone value of …

Abstract Coronavirus Disease 2019 (COVID‐19) pandemic is a rapidly evolving public
health problem. The severity of COVID‐19 cases reported hitherto has varied greatly from …

Recently, there has been increased consideration of real-world data (RWD) and real-world
evidence (RWE) in regulatory and health technology assessment (HTA) decision-making …

Sickle cell disease (SCD) is an inherited, progressively debilitating blood disorder.
Emerging gene therapies (GTx) may lead to a complete remission, the benefits of such can …

Importance Adherence to screening for vision-threatening proliferative sickle cell retinopathy
is limited among patients with sickle cell hemoglobinopathy despite guidelines …

Introduction Sickle cell disease mainly affects African Americans, and studies on racial
differences in sickle cell disease outcomes are scanty. This study examined racial and …

Sickle cell disease is an orphan disease affecting ethnic minorities and characterized by
profound systemic manifestations. Although around 100,000 individuals with SCD are living …

The 2022 United States Food and Drug Administration (US FDA) draft guidance on diversity
plan (DP), which will be implemented through the Diversity Action Plans by December 2025 …

The article reports that cross-sectional analysis of 4.6 million children discharged from 45
US pediatric emergency departments and find higher odds of lowvalue care delivery for non …

Background Sickle Cell Disease (SCD) is an inherited condition that is widespread globally
and especially in malaria-endemic West African countries. Limited epidemiological data on …